Clinical trial Recruiting at 1 site Interventional Ages 18 to 89

Yoga breathing and meditation program for people with spinal cord disorders

Official title: Yogic Breathing Exercise and Meditation for People With Spinal Cord Disorders

Run by University of Alabama at Birmingham · NCT07655531 · Data updated 2026-11-12

A virtual 8‑week program uses yogic breathing and meditation to see if it improves breathing, fatigue, mood, and quality of life for adults with spinal cord disorders.

Quick facts

Study typeInterventional
Ages18 Years to 89 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedJuly 22, 2026
Main results expectedJune 2028
Study endsJune 2029
Registry record updatedJuly 23, 2026
Trial IDNCT07655531 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with spinal cord disorders who can access the internet, use videoconferencing, follow simple instructions, and complete questionnaires in English.

Probably not a fit

Individuals who do not respond to yogic breathing techniques or who have conditions that interfere with participation may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests an 8‑week, coach‑guided yogic breathing and meditation program delivered via Zoom for adults with spinal cord disorders. Participants complete questionnaires at three time points, undergo a 25‑minute interview after the program, and attend two 30‑minute sessions per week for breathing and meditation. The study aims to see whether the program can improve quality of life and mental health, as well as breathing and fatigue, in this population. Risks include tiredness, frustration from learning the techniques, and potential loss of confidentiality. The study is led by the University of Alabama at Birmingham and runs there with online participation and remote data collection.

Why it matters

Potential benefit: If successful, participants may experience better breathing, reduced fatigue, and improved emotional well‑being and quality of life.

How similar studies have gone: Prior studies have explored yogic breathing for various conditions, but results in spinal cord disorders are limited and this approach is relatively novel for this specific population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* spinal cord disorders
* community-dwelling adults aged ≥ 18 years
* able to follow simple, three-step verbal instructions (e.g., close your eyes, open your mouth, close your mouth)
* access to the internet and an electronic device with videoconferencing capability
* able to set up virtual sessions with/without caregiver assistance
* sufficient English language proficiency to provide consent for study participation and complete self-report questionnaires

Exclusion Criteria:

* suicidal intent requiring emergency care
* bedridden with continuous use of noninvasive ventilation
* participating in weekly pulmonary PT, psychological therapy, or a clinical trial that could affect proposed study outcomes.

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

  • Principal investigator: Hon Yuen, PhD — University of Alabama at Birmingham
  • Study coordinator: Hon Yuen, PhD
  • Email: yuen@uab.edu
  • Phone: 12059346301

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.